Shalin is an accomplished life sciences industry management consultant, having consulted for various pharmaceutical manufacturers of all sizes throughout his nearly ten year career. Focused primarily on government and commercial contract operations and strategy, government price reporting, and regulatory compliance, Shalin also has experience working in other areas of commercialization including product launch and channel and distribution strategies in various therapeutic areas. His keen attention to detail, thorough understanding of the healthcare regulatory landscape and unique cross-functional experience has helped manufacturers mitigate risk while staying compliant with the government programs, while also optimizing their business operations.
Recent Finsights Blog Posts
- Attending the CBI HUB and SPP Model Optimization Conference
- 340B Program Management in the Wake of HRSA’s “Mega Rule” Withdrawal
- Survival of the Most Adaptable: Are You Change-Ready?